SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for Picard Medical, Inc. (PMI) (CIK 0002030617) (PMI) — May 26, 2026

Picard Medical, Inc. (PMI) (CIK 0002030617)
Date: May 26, 2026 · CIK: 0002030617 · Accession: 0000000000-26-005353

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-296060

Date
May 26, 2026
Author
Patrick NJ Schnegelsberg
Form
UPLOAD
Company
Picard Medical, Inc. (PMI) (CIK 0002030617)

Letter

May 26, 2026 Patrick NJ Schnegelsberg Chief Executive Officer Picard Medical, Inc. 1992 E Silverlake Tucson, AZ 85713 Re: Picard Medical, Inc. Registration Statement on Form S-1 Filed May 20, 2026 File No. 333-296060 Dear Patrick NJ Schnegelsberg: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Margaret Sawicki at 202-551-7153 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Ben Smolij, Esq.

Show Raw Text
May 26, 2026
Patrick NJ Schnegelsberg
Chief Executive Officer
Picard Medical, Inc.
1992 E Silverlake
Tucson, AZ 85713
Re: Picard Medical, Inc.
Registration Statement on Form S-1
Filed May 20, 2026
File No. 333-296060
Dear Patrick NJ Schnegelsberg:
 This is to advise you that we have not reviewed and will not review your registration
statement.
 Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
 Please contact Margaret Sawicki at 202-551-7153 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and Services
cc: Ben Smolij, Esq.